Tobramycin dosing in cystic fibrosis.
Smyth
Alan
A
Touw
Daan
D
Tan
Kelvin H-V
KH
Bertenshaw
Carol
C
Stableforth
David
D
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications / Q000382:microbiology* / Q000503:physiopathology; D004334:Drug Administration Schedule; D006801:Humans; D007668:Kidney / Q000187:drug effects; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy*; D014031:Tobramycin / Q000008:administration & dosage* / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D014031:Tobramycin